Tuesday, Abiomed, Inc. (ABMD), a maker of heart devices, reported a narrower loss for the fourth quarter, as revenues rose 12% year-on-year.
The Danvers, Massachusetts-based company reported a fourth-quarter net loss of $8.45 million or $0.23 per share, compared to a loss of $14.97 million or $0.46 per share in the same quarter last year.
On a non-GAAP basis, net loss was $6.3 million or $0.17 per share, compared to a loss or $7.9 million or $0.24 per share in the year ago quarter.
On average, 10 analysts polled by Thomson Reuters expected the company to report a loss of $0.16 per share for the quarter. Analysts' estimates typically exclude special items.
Total revenue for the quarter was $19.58 million, up 12% from $17.51 million in the comparable quarter last year. Analysts expected the company to report revenue of $20.53 million for the quarter.
Research and development expenses increased to $7.13 million from $6.69 million in the previous year quarter. Total costs and expenses for the quarter increased to $27.75 million from $26.40 million in the prior year quarter.
For the full year, Abiomed reported a net loss of $31.60 million or $0.91 per share, narrower than $40.93 million or $1.26 per share loss a year ago. On a non-GAAP basis, net loss was $21.2 million or $0.61 per share, compared to $27.7 million or $0.85 per share last year. Analysts expected the company to report a loss of $0.84 per share for the full year.
Total revenue was $73.2 million, up 24% from $58.94 million in the comparable year. Nine Wall Street analysts expected the company to report revenue of $74.09 million for the full year.
"Fiscal 2009 showcased the U.S. market demand for Impella 2.5 minimally invasive heart recovery technology, demonstrated by its rapid adoption and utilization, during a difficult financial time for our customers," said Michael Minogue, Abiomed's chairman, president and chief executive officer.
ABMD closed Monday's regular trading at $6.86 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.